Titan Biotech Limited (BOM:524717)
India · Delayed Price · Currency is INR 434.10
+5.65 (1.32%)
At close: Jun 19, 2026
Titan Biotech Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 298.85 | 215.32 | 248.53 | 248.44 | 216.84 |
Depreciation & Amortization | 49.25 | 41.5 | 33.04 | 25.74 | 23.47 |
Other Amortization | - | 0.2 | 0.27 | 0.27 | 0.22 |
Provision & Write-off of Bad Debts | 3.63 | - | - | - | - |
Other Operating Activities | 16.44 | -20.32 | 2.4 | -33.07 | 13.18 |
Change in Accounts Receivable | -46 | -0.95 | 24.5 | -45.19 | 20.32 |
Change in Inventory | -49.49 | -51.52 | -94.02 | -14.9 | -78.52 |
Change in Accounts Payable | 8.86 | 18.48 | -21.82 | 13.89 | 24.88 |
Change in Other Net Operating Assets | 22.66 | -1.47 | 18.57 | 16.6 | - |
Operating Cash Flow | 304.21 | 201.23 | 211.46 | 211.78 | 220.41 |
Operating Cash Flow Growth | 51.17% | -4.84% | -0.15% | -3.91% | 15.50% |
Capital Expenditures | -74.44 | -93.69 | -194.85 | -127.34 | -63.11 |
Sale of Property, Plant & Equipment | 0.04 | 0.16 | 2.21 | 2.94 | - |
Sale (Purchase) of Intangibles | 0.16 | -0.47 | -0.37 | -0.07 | - |
Investment in Securities | -251.22 | -13.02 | -115.97 | -75.55 | -27.56 |
Other Investing Activities | -18.69 | 8.27 | 105.94 | -7.24 | -73.69 |
Investing Cash Flow | -344.15 | -98.75 | -203.04 | -207.25 | -164.37 |
Short-Term Debt Issued | 14.26 | - | 0.18 | 2.49 | - |
Long-Term Debt Issued | 14.84 | - | 1.54 | 1.15 | - |
Total Debt Issued | 29.11 | - | 1.72 | 3.64 | - |
Short-Term Debt Repaid | - | -48 | - | - | -9.91 |
Long-Term Debt Repaid | - | -7.07 | -3.81 | -7.82 | -9.96 |
Total Debt Repaid | - | -55.06 | -3.81 | -7.82 | -19.87 |
Net Debt Issued (Repaid) | 29.11 | -55.06 | -2.09 | -4.18 | -19.87 |
Common Dividends Paid | -16.53 | -16.53 | -14.88 | -12.4 | -12.4 |
Other Financing Activities | -9.14 | -8.02 | -11.7 | -7.46 | -8.72 |
Financing Cash Flow | 3.44 | -79.61 | -28.66 | -24.03 | -40.99 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | 0 |
Net Cash Flow | -36.5 | 22.88 | -20.24 | -19.5 | 15.05 |
Free Cash Flow | 229.77 | 107.55 | 16.61 | 84.45 | 157.29 |
Free Cash Flow Growth | 113.64% | 547.32% | -80.33% | -46.31% | -2.13% |
Free Cash Flow Margin | 11.14% | 6.87% | 1.01% | 5.86% | 12.73% |
Free Cash Flow Per Share | 5.56 | 2.60 | 0.40 | 2.04 | 3.81 |
Cash Interest Paid | 9.14 | 4.4 | 7.96 | 4.5 | 5.99 |
Cash Income Tax Paid | 85.48 | 59.9 | 78.7 | 75 | 71.18 |
Levered Free Cash Flow | 151.82 | 64.85 | -46.26 | 28.91 | 107.87 |
Unlevered Free Cash Flow | 157.53 | 67.61 | -41.28 | 31.73 | 111.62 |
Change in Working Capital | -63.97 | -35.46 | -72.77 | -29.6 | -33.31 |